Study demonstrates accuracy for a proof-of–concept non-invasive glycemic status screening device. Know Labs, Inc. (NYSE American: KNW), a leading...
Latest clinical research results demonstrate a stable MARD in an expanded dataset. Know Labs, Inc. (NYSE American: KNW), a leading developer of...
The Company’s experience in developing novel, next generation medical diagnostic technology aligns with the Wyss Diagnostics Accelerator’s...
Somogyi to lead Know Labs’ “Skunkworks” Program and drive global revenues. Know Labs, Inc. (NYSE American: KNW), an emerging leader in...
Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the...
The Company’s oral abstract presentation features results from its clinical study that demonstrate the accuracy and medical application of its...
Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast...
The Company demonstrates significant progress since presenting at last year’s Summit. Know Labs, Inc. (NYSE American: KNW), an emerging developer...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.